Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
My bio page
Edit user profile
Signature
Reset the password
Home
About Us
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
Archive
A peer-reviewed protocol journal. No publication fee; no access fee.
Search
Overview
Published
Edited
Reviewed
Following
Feedback
Q&A
HongLok Lung
University of Hong Kong
61 protocols
Tim Smith
University of Aberdeen
4 protocols
Vanesa Olivares-Illana
Instituto de Física, Universidad Autónoma de San Luis Potosí
15 protocols
View all coreviewers >
Reviewer
Shyam Srivats
Research scientist, University of California, San Francisco
Research focus
Cancer biology
Cancer biology, cell biology, immunology, cell therapy
Contributions
Reviewer merit
Editor merit
Education
PhD
Publications
https://www.ncbi.nlm.nih.gov/pubmed/?term=shyam+srivats
1 Protocol reviewed
Virtual Screening of Transmembrane Serine Protease Inhibitors
Authors:
Antti Poso
,
Topi Tervonen
and
Juha Klefström
,
date:
04/20/2017,
view:
5937,
Q&A:
0
The human family of type II transmembrane serine proteases includes 17 members. The defining features of these proteases are an N-terminal transmembrane domain and a C-terminal serine protease of the chymotrypsin (S1) fold, separated from each other ...
More >
following
More protocols >
0 Protocol feedback
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.